Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 33.84M 39.45M 31.6M 28.99M 54.52M 3.77B 55.42M 373M 146M 1.89B 148M 145M 6.25B | P/E 2026 * |
-5.49x | P/E 2027 * | 38.4x |
|---|---|---|---|---|---|
| Enterprise Value | 33.84M 39.45M 31.6M 28.99M 54.52M 3.77B 55.42M 373M 146M 1.89B 148M 145M 6.25B | EV / Sales 2026 * |
11.3x | EV / Sales 2027 * | 3.38x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 39.45M | |
| +12.60% | +14.50% | +79.21% | +39.38% | 376B | |
| -1.45% | -2.08% | +22.35% | -13.52% | 70.12B | |
| +2.60% | +5.73% | +53.79% | +148.77% | 12.21B | |
| +1.37% | +0.48% | -0.94% | +1.63% | 8.55B | |
| +0.12% | -3.29% | -12.69% | -1.39% | 4.8B | |
| 0.00% | -4.21% | -30.05% | +14.02% | 4.27B | |
| -8.17% | -24.30% | -27.12% | +13.46% | 3.2B | |
| -1.00% | +1.40% | +15.57% | +56.73% | 2.82B | |
| -2.79% | -4.95% | -9.56% | -6.03% | 2.13B | |
| Average | -1.65% | -1.90% | +10.06% | +28.12% | 53.74B | |
| Weighted average by Cap. | +0.38% | +10.98% | +65.56% | +32.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.5M 2.8M 2.57M 4.83M 334M 4.91M 33.05M 12.94M 168M 13.13M 12.85M 554M | 10M 11.66M 9.34M 8.57M 16.11M 1.11B 16.38M 110M 43.15M 559M 43.77M 42.82M 1.85B |
| Net income | -6M -6.99M -5.6M -5.14M -9.67M -669M -9.83M -66.11M -25.89M -335M -26.26M -25.69M -1.11B | 1M 1.17M 934K 857K 1.61M 111M 1.64M 11.02M 4.31M 55.88M 4.38M 4.28M 185M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
